Alzheimer’s disease | TDP-43, mir-137/181b, BACE1AS |
Down syndrome | TDP-43 |
Frontotemporal lobar dementia | TDP-43 |
Amyotrophic lateral sclerosis | TDP-43, mir-206 |
Familial British dementia | TDP-43 |
Parkinson’s disease | TDP-43, BC200, SOX20T, mir-34b/c, mir-153 |
Huntington’s disease | HAR1, DGCR5, TDP-43, FUS/TLS, TUG1, NEAT 1, toxic RNA, mir-132, mir-7, mir-34b |
Spinocerebellar ataxia 1, 2, 3, 4 | FUS/TLS |
Spinocerebellar ataxia 10, 12 | Toxic RNA, RAN (repeat associated non ATG translation), expansion in non coding region |
Dentatorubral-pallidoluysian atrophy | FUS/TLS |
Myopathies | TDP-43 |
Fragile X tremor ataxia syndrome | Antisense transcription, expansion in non coding region |
X-linked mental retardation | UPF3B mutation |
Autism | 7q22-q33 (non coding RNA) |
Spinal muscular atrophy | Mutation in SMN2 |
Spinocerebellar ataxia | Non coding RNA |
Myotonic dystrophy type 1 (DM1) | RAN (repeat associated non ATG translation), expansion in non coding region |
Myotonic dystrophy type 2 (DM2) | Expansion in non coding region |